Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-24

Clinical Trial Update: Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach

View source ↗

Summary

NIDDK-funded clinical trial is investigating the mechanisms of primary sclerosing cholangitis through multidisciplinary, integrative research. The study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Primary Sclerosing Cholangitis | Status: RECRUITING